Chinese Journal of Diabetes is an academic journal focused on diabetes, organized by Peking University. It primarily caters to healthcare professionals specializing in diabetes and aims to report leading research findings, clinical diagnostic experiences, and fundamental theoretical research that have practical significance and are closely linked to clinical practice.
Section 1: Scope of Submissions
The journal welcomes submissions for articles, short papers, case reports, clinical experiences, technical exchanges, lectures, reviews, conference summaries, discussions on clinical pathology (case), and domestic and international academic updates.
Section 2: Submission Requirements
1. Manuscripts should be innovative, scientific, practical, and logical, with accurate and reliable data. The arguments should be clear, and the writing should be concise. If necessary, statistics should be included. The length of articles, reviews, and lectures generally should not exceed 5,400 characters. Short papers should not exceed 4,500 characters, and case reports should not exceed 2,000 characters (including figures, tables, and references). The title should be concise and eye-catching, with no more than 20 Chinese characters.
2. The names and order of authors should be finalized at the time of submission and should not be changed afterward. If there are foreign authors, a letter of consent for publication in this journal, signed by the author (on official letterhead), should be provided. If the research was conducted in a foreign laboratory, a statement of consent to publish from that laboratory should be included.
3. Abstracts: Articles should include both Chinese and English abstracts. The abstract should consist of four parts: objectives, methods, results (highlighting key data), and conclusions. The Chinese abstract should be around 200 Chinese characters, while the English abstract should be relatively specific (around 300 real English words). Short papers should include Chinese and English summaries. The Chinese summary should be within 100 Chinese characters, while the English summary should be around 60 real English words.
4. Keywords: Articles should include 2-5 keywords. Whenever possible, please use the latest edition of "Index Medicus," a medical subject heading list published by the National Library of Medicine in the United States. Abbreviations in the keywords should be expanded to their full forms according to the "Index Medicus."
5. Medical terminology should adhere to the "Medical Nomenclature" published by the National Committee for the Standardization of Scientific and Technical Terminology since 1989. For terms that have not yet been published, the "English-Chinese Medical Vocabulary" compiled by the People's Health Publishing House should be used as a reference. Drug names should be given using the scientific name or the names provided in the "Drug Vocabulary" and "Chinese Generic Drug Nomenclature" edited by the Drug Editorial Committee of the Ministry of Health, and not the trade names.
6. Figures and tables should be sequentially numbered according to their appearance in the main text. Explanatory information for figures and tables should be placed below them, and any non-standard English abbreviations should be indicated in Chinese. Figures, tables, and photographs should be concise and avoid repetitive content. The main text should avoid repeating the data presented in the figures and tables. The back of the photographs should include the manuscript number, figure number, author's name, and the orientation of the image. The titles and content of the figures and tables should be written in both Chinese and English. Pathological photographs should indicate staining methods and magnification. Clear original photographs should be provided for illustrations, and photocopies will not be accepted. Symbols (including arrows) that need to be labeled in the figures should be indicated on a separate sheet. Written consent from individuals is required if using their portraits.
7. Measurement units should follow the "Legal Metrological Units of the People's Republic of China" issued by the State Council in February 1984. Please ensure consistent use of unit names and symbols. Blood pressure should be measured in millimeters of mercury. Symbols for quantities should be italicized, for example, the symbol for absorbance is "A." For the introduction of new drugs mentioned in the article, their approval numbers or import drug registration numbers must be provided.
8. Numeric usage should follow the specifications of GB/T 15835-1995 "Specifications for Numeric Usage in Publications." Centuries, decades, years, months, days, hours, and counts should be written using Arabic numerals. Percentages and ranges should be written as 15%~35% and (45.2±0.4)%, respectively. When multiplying numerical values with accompanying length units, write them as follows: 3cm × 4cm × 5cm.
9. In statistical reports, conclusions from statistical tests are generally expressed using three forms: P>0.05, P<0.05, and P<0.01. For P-values less than or equal to the significance level, they should be described as "statistically significant differences" rather than "significant differences."
10. Abbreviations should have their Chinese full names written out first, followed by the English full names and their abbreviations in parentheses at their first appearance.
11. References should be cited in accordance with GB 7714-87 "Rules for the Bibliographic Citation of References at the End of Documents" using a numerical system. The references should be numbered in square brackets in the order of their appearance in the text. For references with multiple authors, list all authors if there are between 1 to 3 authors; if there are more than 3 authors, list the first 3 followed by "et al." Abbreviations should be used for foreign journal names according to the format in "Index Medicus," while the full name should be used for Chinese journals. When citing books, the edition should be specified. The page range should be included for all references. Examples:
1. Ouyang Lingli, Zhou Zhiguang, Peng Jian, et al. Preliminary clinical observation of Tripterygium glycosides in the treatment of LADA. Chinese Journal of Diabetes, 2000, 8: 7-9.
2. Harding AH, Sargeant LA, Welch A, et al. Fat consumption and HbA1c levels. Diabetes Care, 2000, 24: 1911-1916.
3. Qian Rongli. Islet hormones and antidiabetic drugs. In: Yang Zaochen, ed. Pharmacology and Pharmacotherapy (Volume II). Beijing: People's Health Publishing House, 2000. 1273-1296.
4. Karam JH. Hypoglycemic disorders. In: Greenspan FS, Gardner DF, eds. Basic & clinical endocrinology. 6th ed. New York: McGraw-Hill, 2000. 699-715.
12. Research papers supported by national or above-provincial level funds or classified as key research projects should include a footnote on the lower left corner of the first page stating: "Funded by ×× Project (Grant No. ××)," and a copy of the funding certificate should be attached.
13. Two copies of the manuscript should be provided, printed on one side of the paper with 29 lines and 35 characters per line, double-spaced. The handwriting must be clear. The submission should include a recommendation letter from the author's institution, indicating their evaluation of the manuscript and confirming that it has not been submitted to another journal simultaneously and that there is no dispute over authorship. To expedite the review process, contact information (postal code, detailed address, department of the institution, telephone, and email) should be provided.
Section 3: Acknowledgment of Manuscript and Review Process
Acknowledgment of receipt of the manuscript will be sent to the first author via email. If no notification of manuscript acceptance or rejection is received within 3 months after receiving the acknowledgment, it means that the manuscript is still under review. Authors should keep a copy of the manuscript. The Editorial Office will be responsible for notifying the authors of the decision not to proceed with their manuscript, and the original manuscript will not be returned.
Section 4: Author Responsibility and Copyright
Authors bear full responsibility for the content of their manuscripts. In accordance with the "Copyright Law," the journal has the right to make textual modifications and deletions to the submitted manuscript. If a revised manuscript is not sent back within 3 months, it will be considered an automatic withdrawal; however, it will not be considered as a rejection, and the revised version can still be resubmitted as a new manuscript. If authors have different views on the withdrawal decision, a written appeal can be submitted.
Section 5: Fees and Compensation
A review fee of 100 RMB is required upon submission. Once the manuscript is accepted for publication, a page fee will be charged as per the specified amount. Additional fees may apply for the printing of color figures. After publication, authors will receive remuneration and two complimentary copies of the current issue of the journal.
Section 6: Copyright Agreement and Submission
Upon acceptance for publication, authors are required to sign a copyright agreement granting exclusive use rights to Chinese Journal of Diabetes.
Section 7: Submission Procedure
Please send manuscripts to: Editorial Office, Chinese Journal of Diabetes, 37 Xishiku Street, Xicheng District, Beijing, Postal Code 100034, China. Do not send manuscripts to individuals. Email: journal@cds.org.cn; Website: www.cds.org.cn. Online submissions are welcome.